Published in Life Sci on January 01, 1998
The effects of endomorphin-1 and endomorphin-2 in CHO cells expressing recombinant mu-opioid receptors and SH-SY5Y cells. Br J Pharmacol (1999) 0.85
Bioactive peptides of animal origin: a review. J Food Sci Technol (2015) 0.82
Endomorphin-2 is released from newborn rat primary sensory neurons in a frequency- and calcium-dependent manner. Eur J Neurosci (2008) 0.79
Effects of nociceptin and nocistatin on antidromic vasodilatation in hairless skin of the rat hindlimb in vivo. Br J Pharmacol (1999) 0.78
Effect of Endomorphins on HUVECs Treated by ox-LDL and Its Related Mechanisms. J Diabetes Res (2016) 0.75
Endomorphin-1 induced desensitization and down-regulation of the recombinant mu-opioid receptor. Br J Pharmacol (2000) 0.75
Engineering endomorphin drugs: state of the art. Expert Opin Ther Pat (2012) 0.75
Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther (1981) 6.71
Leptin enters the brain by a saturable system independent of insulin. Peptides (1996) 3.97
A potent and selective endogenous agonist for the mu-opiate receptor. Nature (1997) 3.87
The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol (1985) 3.29
Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. J Pharmacol Exp Ther (1981) 3.14
Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucleotide Res (1979) 3.11
Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology (1998) 2.89
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapulmonary artery and vein: stimulation by acetylcholine, bradykinin and arachidonic acid. J Pharmacol Exp Ther (1986) 2.64
Hypertriiodothyroninaemia as a premonitory manifestation of thyrotoxicosis. Lancet (1971) 2.58
Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science (1971) 2.43
Awareness, diagnosis, and treatment of depression. J Gen Intern Med (1999) 2.30
Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol (1993) 2.08
Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim Biophys Acta (1982) 2.00
Passage of cytokines across the blood-brain barrier. Neuroimmunomodulation (1996) 1.94
Disproportionate elevation of N-terminal pro-brain natriuretic peptide in scleroderma-related pulmonary hypertension. Eur Respir J (2009) 1.85
Association between cyclic GMP accumulation and acetylcholine-elicited relaxation of bovine intrapulmonary artery. J Pharmacol Exp Ther (1984) 1.85
Addition of sildenafil to bosentan monotherapy in pulmonary arterial hypertension. Eur Respir J (2006) 1.79
Methylene blue inhibits coronary arterial relaxation and guanylate cyclase activation by nitroglycerin, sodium nitrite, and amyl nitrite. Can J Physiol Pharmacol (1981) 1.74
Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun (2001) 1.74
Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation. Mol Pharmacol (1983) 1.68
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
Certified athletic trainers in secondary schools: report of the council on scientific affairs, american medical association. J Athl Train (1999) 1.66
Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin. Peptides (1998) 1.58
Human interleukin (IL) 1 alpha, murine IL-1 alpha and murine IL-1 beta are transported from blood to brain in the mouse by a shared saturable mechanism. J Pharmacol Exp Ther (1991) 1.57
In vivo gene transfer of prepro-calcitonin gene-related peptide to the lung attenuates chronic hypoxia-induced pulmonary hypertension in the mouse. Circulation (2000) 1.55
Prostaglandins as modulators of the autonomic nervous system. Fed Proc (1974) 1.54
Influence of acetylcholine on contractile force and cyclic nucleotide levels in the isolated perfused rat heart. J Pharmacol Exp Ther (1973) 1.48
Activity and specificity of synthetic thyrotropin-releasing hormone in man. Biochem Biophys Res Commun (1970) 1.47
Isolation and structure of hypothalamic MSH release-inhibition hormone. Biochem Biophys Res Commun (1971) 1.43
Hypothalamic regulatory hormones. Science (1973) 1.41
Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin secretion in man. N Engl J Med (1971) 1.40
Blood-borne interleukin-1 receptor antagonist crosses the blood-brain barrier. J Neuroimmunol (1994) 1.38
Differential distribution of endomorphin 1- and endomorphin 2-like immunoreactivities in the CNS of the rodent. J Comp Neurol (1999) 1.36
Hypothalamic neurohormones regulating anterior pituitary function. Recent Prog Horm Res (1968) 1.36
Hypothalamic follicle-stimulating hormone (FSH) and luteinizing hormone (LH)-regulating hormone: structure, physiology, and clinical studies. Fertil Steril (1971) 1.35
Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett (1994) 1.32
Coronary arterial relaxation and guanylate cyclase activation by cigarette smoke, N'-nitrosonornicotine and nitric oxide. J Pharmacol Exp Ther (1980) 1.31
The hypothalamus and reproduction. Am J Obstet Gynecol (1972) 1.29
Differential permeability of the BBB in acute EAE: enhanced transport of TNT-alpha. Am J Physiol (1996) 1.26
Potentiation of adrenergic venomotor responses by angiotensin, prostaglandin F 2 and cocaine. J Pharmacol Exp Ther (1971) 1.26
Growth hormone release inhibiting hormone in acromegaly. Br Med J (1974) 1.24
Relaxation of intrapulmonary artery and vein by nitrogen oxide-containing vasodilators and cyclic GMP. J Pharmacol Exp Ther (1984) 1.23
DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF). Life Sci I (1971) 1.23
Selective, physiological transport of insulin across the blood-brain barrier: novel demonstration by species-specific radioimmunoassays. Peptides (1997) 1.22
Passage of human amyloid beta-protein 1-40 across the murine blood-brain barrier. Life Sci (1994) 1.21
Clinical experience with hypothalamic releasing hormones. 1. Thyrotropin-releasing hormone. Recent Prog Horm Res (1972) 1.21
Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides (1997) 1.20
Differences in responsiveness of intrapulmonary artery and vein to arachidonic acid: mechanism of arterial relaxation involves cyclic guanosine 3':5'-monophosphate and cyclic adenosine 3':5'-monophosphate. J Pharmacol Exp Ther (1985) 1.20
Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci (1991) 1.19
Altered high-energy phosphate metabolism predicts contractile dysfunction and subsequent ventricular remodeling in pressure-overload hypertrophy mice. Am J Physiol Heart Circ Physiol (2006) 1.18
Adsorptive endocytosis mediates the passage of HIV-1 across the blood-brain barrier: evidence for a post-internalization coreceptor. J Cell Sci (1998) 1.18
Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat. Proc Natl Acad Sci U S A (1999) 1.16
A rat model of Peyronie's disease associated with a decrease in erectile activity and an increase in inducible nitric oxide synthase protein expression. J Urol (2000) 1.16
Bidirectional transport of interleukin-1 alpha across the blood-brain barrier. Brain Res Bull (1989) 1.15
Adsorptive endocytosis of HIV-1gp120 by blood-brain barrier is enhanced by lipopolysaccharide. Exp Neurol (1999) 1.15
Clinical experience with hypothalamic releasing hormones. 2. Luteinizing hormone-releasing hormone and other hypophysiotropic releasing hormones. Recent Prog Horm Res (1972) 1.13
Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. Lancet (1972) 1.13
Peptide transport systems for opiates across the blood-brain barrier. Am J Physiol (1990) 1.11
L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem Biophys Res Commun (1993) 1.11
Interactions of IGF-1 with the blood-brain barrier in vivo and in situ. Neuroendocrinology (2000) 1.11
Permeability of the blood-brain and blood-spinal cord barriers to interferons. J Neuroimmunol (1997) 1.10
Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability. Brain Res Bull (1985) 1.10
Chronic corticosterone impairs memory performance in the Barnes maze. Physiol Behav (1998) 1.10
Mahogany, blood-brain barrier, and fat mass surge in AVY mice. Int J Obes (Lond) (2007) 1.09
Blood-brain barrier permeability to ebiratide and TNF in acute spinal cord injury. Exp Neurol (1997) 1.09
Effect of diabetes mellitus on the permeability of the blood-brain barrier to insulin. Peptides (1997) 1.08
The putative blood-brain barrier transporter for the beta-amyloid binding protein apolipoprotein j is saturated at physiological concentrations. Life Sci (1997) 1.08
Tumor necrosis factor-alpha: a neuromodulator in the CNS. Neurosci Biobehav Rev (1997) 1.07
Opiate tolerance and dependence: receptors, G-proteins, and antiopiates. Peptides (1998) 1.06
An analog of enkephalin having prolonged opiate-like effects in vivo. Science (1977) 1.06
Granulocyte-macrophage colony-stimulating factor crosses the blood--brain and blood--spinal cord barriers. Brain (1997) 1.06
Increase in TNFalpha transport after SCI is specific for time, region, and type of lesion. Exp Neurol (2001) 1.05
Fate of leptin after intracerebroventricular injection into the mouse brain. Endocrinology (1998) 1.05
Endogenous opiates: 1999. Peptides (2000) 1.05
Proceedings: Effect of somatostatin on motilin levels and gastric emptying. Gut (1975) 1.05
Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier. J Pharmacol Exp Ther (1993) 1.04
Aluminum-induced neurotoxicity: alterations in membrane function at the blood-brain barrier. Neurosci Biobehav Rev (1989) 1.04
Dissimilarities between methylene blue and cyanide on relaxation and cyclic GMP formation in endothelium-intact intrapulmonary artery caused by nitrogen oxide-containing vasodilators and acetylcholine. J Pharmacol Exp Ther (1986) 1.03
Melanocyte-stimulating hormone-release inhibiting hormone as a antidepressant. A pilot study. Arch Gen Psychiatry (1974) 1.03
Diurnal variation of leptin entry from blood to brain involving partial saturation of the transport system. Life Sci (2001) 1.03
Glucagon control of fasting glucose in man. Lancet (1974) 1.02
Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine. Peptides (1994) 1.02
Influence of prostaglandins E1 and F2alpha on pulmonary vascular resistance, isolated lobar vessels and cyclic nucleotide levels. J Pharmacol Exp Ther (1975) 1.02
Pulmonary vasodilator activity of prostacyclin (PGI2) in the cat. Circ Res (1979) 1.02
Evidence that regulation of hepatic guanylate cyclase activity involves interactions between catalytic site -SH groups and both substrate and activator. Arch Biochem Biophys (1981) 1.01
Permeability of the blood-brain barrier to amylin. Life Sci (1995) 1.01
Pulmonary and systemic vasodilator effects of the newly discovered prostaglandin, PGI2. J Appl Physiol Respir Environ Exerc Physiol (1978) 1.01
Effect of synthetic hypothalamic gonadotropin-releasing hormone (FSH-LH-RH) in anovulatory sterility. Fertil Steril (1974) 1.01
Assessment of pulmonary vasculature and right heart by invasive haemodynamics and echocardiography. Int J Clin Pract Suppl (2009) 1.01
Quantifying carrier-mediated transport of peptides from the brain to the blood. Methods Enzymol (1989) 1.01